NPPA fixes retail prices of 39 formulations

The National Pharmaceutical Pricing Authority (NPPA) has announced that it has fixed retail prices of 39 formulations under the Drugs (Prices Control) Order, 2013. The price fixation is based on the decision of the 120th Authority meeting dated 24.01.2024.

The formulations whose prices have been fixed include Prosperity Drugs and Torrent Pharma's Paracetamol and Dicyclomine Hydrochloride Tablets, Abbott India's Zolpidem Tartrate Prolonged release tablets, Pure and cure Healthcare and Dr Reddy's Labs' Rosuvastatin plus Clopidogrel Capsules, Curetech Skincare and J.B. Chemicals & Pharma's Diclofenac Diethylamine, Virgin Linseed Oil, Methyl Salicylate, Menthol & Capsacin Gel.

The list further includes Synokem Pharmaceuticals and Mankind Pharma's Linagliptin, Metformin Hydrochloride (Extended Release) Tablets, Mascot Health Series and Lupin's Sitagliptin Phosphate, Metformin Hydrochloride and Glimepiride Tablets, Sun Pharma Laboratories' Dapagliflozin, Metformin Hydrochloride Extended Releaseand Glimepiride Tablets.

For the full story, check out the link given below:

NPPA Fixes Price For Various FDCs Having Sitagliptin, Linagliptin